Key Details
Price
$6.91Last Dividend
$0.15TTM Dividend Yield
2.22%PE Ratio
9.89Annual ROE
4.89%Beta
1.21Events Calendar
Next earnings date:
Apr 25, 2025Recent quarterly earnings:
Feb 5, 2025Recent annual earnings:
Apr 26, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Sep 30, 2024Next split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Price
Market cap
Technical
Dividend
Events
Dividend per share
Dividend yield
Other
Profitability
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Liquidity
Leverage
Risk & Stability
Balance Sheet
Assets
Equity
Liabilities
Debt
Expenses
Cash Flow
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
Is Nomura Holdings (NMR) a strong choice for momentum investors? Let's take a closer look.
Investors looking at stocks in the Financial - Investment Bank sector may be familiar with Nomura Holdings (NMR) and Bank of America (BAC). However, which of these two stocks is more appealing to value investors?
Nomura (NMR) has formed a hammer chart pattern, suggesting that the stock has found support after a recent decline. Additionally, an increase in earnings estimate revisions may signal a potential trend reversal for the stock soon.
At Zacks, we concentrate on the reliable Zacks Rank system, which highlights earnings estimates and changes in those estimates to identify excellent stocks. However, we also keep an eye on the most recent trends in value, growth, and momentum to support our top selections.
CALGARY, AB, Dec. 11, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR instruments and MRI technology for industrial and research uses, has announced the results of a study by the United States Pharmacopeia (USP) that shows benchtop NMR is effective for quality control of active pharmaceutical ingredients (API). Sean Krakiwsky, the Founder and CEO of Nanalysis, stated that they believe benchtop NMR will soon play a significant role in the multi-billion-dollar pharmaceutical quality control market.
NEW YORK, Nov. 10, 2024 /PRNewswire/ -- Pomerantz LLP is looking into claims for investors of Nomura Holdings, Inc. ("Nomura" or the "Company") (NYSE: NMR). Investors are encouraged to reach out to Danielle Peyton at [email protected] or call 646-581-9980, ext.
Pomerantz LLP is looking into claims for investors of Nomura Holdings, Inc. ("Nomura" or the "Company") (NYSE:NMR) as of November 4, 2024. Investors who are interested should reach out to Danielle Peyton at [email protected] or call 646-581-9980, ext.
NEW YORK, Nov. 2, 2024 /PRNewswire/ -- Pomerantz LLP is looking into claims for investors of Nomura Holdings, Inc. ("Nomura" or the "Company") (NYSE: NMR). Investors are encouraged to reach out to Danielle Peyton at [email protected] or call 646-581-9980, ext.
Nomura Holdings, Inc. (NYSE:NMR) will hold its Q2 2025 Earnings Conference Call on November 1, 2024, at 5:30 AM ET. The call will feature company participants, including Chief Financial Officer Takumi Kitamura, and various conference call participants from different securities firms. Please note that this call is being recorded as requested by the company.
Pomerantz LLP is looking into claims for investors of Nomura Holdings, Inc. ("Nomura" or the "Company") (NYSE:NMR) as of October 31, 2024. Investors who have concerns are encouraged to reach out to Danielle Peyton at [email protected] or call 646-581-9980, ext.
FAQ
- What is the ticker symbol for Nomura Holdings?
- Does Nomura Holdings pay dividends?
- What sector is Nomura Holdings in?
- What industry is Nomura Holdings in?
- What country is Nomura Holdings based in?
- When did Nomura Holdings go public?
- Is Nomura Holdings in the S&P 500?
- Is Nomura Holdings in the NASDAQ 100?
- Is Nomura Holdings in the Dow Jones?
- When was Nomura Holdings's last earnings report?
- When does Nomura Holdings report earnings?